J Liver Cancer Search

CLOSE


Review Article

April 22, 2022


Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun Kim
J Liver Cancer. 2022;22(2):93-102.

Review Article

September 22, 2022


Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
J Liver Cancer. 2022;22(2):103-114.

Original Article

May 20, 2022


The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, et al.
J Liver Cancer. 2022;22(2):115-124.

Original Article

June 28, 2022


Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, et al.
J Liver Cancer. 2022;22(2):125-135.

Original Article

September 16, 2022


Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
Jeong Yun Jang, Jinhong Jung, Danbi Lee, et al.
J Liver Cancer. 2022;22(2):136-145.

Original Article

September 14, 2022


Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
Sung Jun Jo, Jinsoo Rhu, Jong Man Kim, et al.
J Liver Cancer. 2022;22(2):146-157.

Original Article

September 27, 2022


Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
Wonjoon Jang, Hye Won Lee, Jae Seung Lee, et al.
J Liver Cancer. 2022;22(2):158-166.

Original Article

September 29, 2022


The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
Young Chang, Soung Won Jeong, Jae Young Jang, et al.
J Liver Cancer. 2022;22(2):167-177.

Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
Hye Won Lee
J Liver Cancer. 2022;22(2):91-92.

Editorial

September 29, 2022

Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun Kim
J Liver Cancer. 2022;22(2):93-102.

Review Article

April 22, 2022

Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
J Liver Cancer. 2022;22(2):103-114.

Review Article

September 22, 2022

The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, et al.
J Liver Cancer. 2022;22(2):115-124.

Original Article

May 20, 2022

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, et al.
J Liver Cancer. 2022;22(2):125-135.

Original Article

June 28, 2022

Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
Jeong Yun Jang, Jinhong Jung, Danbi Lee, et al.
J Liver Cancer. 2022;22(2):136-145.

Original Article

September 16, 2022

Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
Sung Jun Jo, Jinsoo Rhu, Jong Man Kim, et al.
J Liver Cancer. 2022;22(2):146-157.

Original Article

September 14, 2022

Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
Wonjoon Jang, Hye Won Lee, Jae Seung Lee, et al.
J Liver Cancer. 2022;22(2):158-166.

Original Article

September 27, 2022

The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
Young Chang, Soung Won Jeong, Jae Young Jang, et al.
J Liver Cancer. 2022;22(2):167-177.

Original Article

September 29, 2022

Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
Seong Kyun Na
J Liver Cancer. 2022;22(2):178-182.

Case Report

June 22, 2022

Novel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case report
Sung Hoon Chang, Tae Suk Kim, Yong Hwan Jeon, et al.
J Liver Cancer. 2022;22(2):183-187.

Case Report

August 24, 2022

Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report
Moon Haeng Hur, Haeryoung Kim, Jeong-Hoon Lee
J Liver Cancer. 2022;22(2):188-193.

Case Report

August 31, 2022

Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report
Choong Hee Kim, Gwang Hyeon Choi, Hee Young Na, et al.
J Liver Cancer. 2022;22(2):194-201.

Case Report

September 15, 2022

Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report
Sangmi Kim, Ji Hoon Kim, Ji Won Han, et al.
J Liver Cancer. 2022;22(2):202-206.

Case Report

September 20, 2022

Yoon et al. Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
Jeong-Hoon Lee
J Liver Cancer. 2022;22(2):207-207.

Notice of Retraction and Replacement

June 8, 2022

  • KoreaMed
  • KoMCI
  • GoogleScholar
  • DOAJ
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID

ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR AUTHORS AND REVIEWERS
Editorial Office
620 Yeoksam Heights Bldg.(FASTFIVE),151 Teheran-ro, Gangnam-gu, Seoul 06132, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2022 by The Korean Liver Cancer Association.

Developed in M2PI

Close layer
prev next
Close layer
prev next